Interpretation on Management of Dyspnea in Advanced Cancer: ASCO Guideline
10.12290/xhyxzz.2023-0517
- VernacularTitle:《晚期癌症患者呼吸困难处理: 美国临床肿瘤学会指南》解读
- Author:
Zhimeng JIA
1
;
Colman REBECCA
2
;
Xiaohong NING
3
Author Information
1. Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts MA 02138, United States;Temmy Latner Centre for Palliative Care, Mount Sinai Hospital, Toronto, M5S 2E8, Canada;Department of Family and Community Medicine, University of Toronto, Toronto, M5S 2E8, Canada;
2. Temmy Latner Centre for Palliative Care, Mount Sinai Hospital, Toronto, M5S 2E8, Canada;Department of Medicine, University Health Network, University of Toronto, Toronto, M5S 2E8, Canada;
3. Department of Geriatrics, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China;Palliative Medicine Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China;
- Publication Type:Journal Article
- Keywords:
late stage cancer;
difficulty breathing;
palliative care;
guideline interpretation
- From:
Medical Journal of Peking Union Medical College Hospital
2024;15(1):52-57
- CountryChina
- Language:Chinese
-
Abstract:
Dyspnea, the subjective sensation of breathlessness, is a common source of distress for patients living with advanced cancer. Effective assessment and management of dyspnea among patients living with advanced cancer represents core competencies for front-line clinicians and professional caregivers. However, there is still a lack of standardized procedures for handling dyspnea in China. Based on evidence-based medicine, the American Society of Clinical Oncology practice guidelines for management of dyspnea in advanced cancer was released, which outlines assessment and management of dyspnea among patients living with advanced cancer. This article aims to provide detailed interpretation of key clinical content to guide China's clinical practice.
